Last update:

HIV & AIDS news

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

Most at-risk populations for HIV discussing the topic in negative, risky ways get the most social media attention

As the old saying goes, bad news travels fast. Research shows that saying holds true when it comes to young men discussing HIV on social media. An analysis of viral tweets from young men and adolescents, the most at-risk ...

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

Study examines novel drug candidate for treatment of neuroHIV

A recently published article in Experimental Biology and Medicine titled "LM11A-31, a modulator of p75 neurotrophin receptor, suppresses HIV-1 replication and inflammatory response in macrophages" highlights the potential ...

HIV & AIDS

War in Ukraine has escalated HIV spread in the country: study

Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

HIV & AIDS

New drug capsule may allow weekly HIV treatment

Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

HIV & AIDS

HIV screening most optimal at 25 years of age if no risk factors

(HealthDay)—For young adults without known risk factors, a one-time routine HIV screen at 25 years would optimize clinical outcomes and be cost-effective, according to a study published in the January issue of the Journal ...

HIV & AIDS

Usage remains low for pill that can prevent HIV infection

From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

HIV & AIDS

Common birth control shot linked to risk of HIV infection

Transitioning away from a popular contraceptive shot known as DMPA could help protect women in Sub-Saharan Africa and other high-risk regions from becoming infected with HIV, according to a research review published in the ...

HIV & AIDS

Kenya's HIV progress report—good progress, but also big gaps

The World Health Organisation (WHO) has clear markers on the road to controlling the global HIV/AIDS pandemic. By 2020, about nine out of every ten people should know their HIV status. Nine out of ten HIV positive people ...

HIV & AIDS

Study establishes benchmarks for HIV vaccine candidates

The development of a vaccine that protects against HIV infections has proven extraordinarily difficult. One of the reasons is that naïve precursor B cells that can give rise to mature B cells producing broadly neutralizing ...

HIV & AIDS

Team develops more accurate tool to track new HIV infections

Researchers at the Duke Human Vaccine Institute have led an effort to develop a more accurate way to gauge the incidence of HIV infections in large populations, which will improve research and prevention strategies worldwide.

HIV & AIDS

New evidence supports HIV screening in young adulthood

A new study suggests that the most beneficial age for a one-time screening HIV test of the general population would be age 25. The report - led by researchers at Massachusetts General Hospital (MGH) working with the U.S. ...